Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Inhibition of hyaluronic acid degradation pathway suppresses glioma progression by inducing apoptosis and cell cycle arrest

Fig. 4

HYAL2 overexpression is related to multiple clinical traits in glioma patients. (A) The relationship between HYAL2 expression and glioma IDH mutation status in the CGGA (mRNA-array_301, mRNAseq_325 and mRNAseq_693) database. (B) The relationship between HYAL2 expression and glioma 1p19q codeletion status in the CGGA (mRNAseq_325 and mRNAseq_693) database. (C) The relationship between HYAL2 expression and glioma recurrence status in the CGGA (mRNAseq_693) database. (D) The relationship between HYAL2 expression and glioma histology in the CGGA (mRNA-array_301, mRNAseq_325 and mRNAseq_693) database. (E) The relationship between HYAL2 expression and glioma patient age in the CGGA (mRNA-array_301 and mRNAseq_325) database. (F) The ROC curve for predicting the one-year, three-year and five-year survival outcomes based on HYAL2 expression in glioma patients. Bars represent the mean ± SD; *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us